- Zacks•6 days ago
Aquinox Pharmaceuticals (AQXP) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
- Capital Cube•2 months ago
Click here to see latest analysisAquinox Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -6.71 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.AQXP-US‘s earnings and EBITDA are […] (Read more...) The post Aquinox Pharmaceuticals, Inc. :AQXP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.
Aquinox Pharmaceuticals Inc.NasdaqGM
After hours: 7.700.00 (0.00%) as of 4:12 PM EDT
|Bid||5.00 x 200|
|Ask||7.75 x 500|
|52wk Range||1.61 - 55.75|
|Day's Range||7.44 - 7.73|
|Avg Vol (3m)||150,853|
As of 4:00 PM EDT. Market closed.